Shendelman Shoshana's most recent trade in Applied Therapeutics Inc was a trade of 747,886 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2024 | 747,886 | 747,886 (4%) | 4% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2024 | 747,886 | 0 (0%) | 4% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 05 Aug 2024 | 357,423 | 4,810,430 (25%) | 1% | 6.2 | 2,208,874 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 05 Aug 2024 | 300,000 | 5,167,853 (27%) | 1% | 6.0 | 1,794,000 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.93 per share. | 05 Aug 2024 | 119,591 | 4,690,839 (25%) | 0% | 5.9 | 709,175 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 61,795 | 3,756,019 (20%) | 0% | 4.3 | 266,954 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 318,573 | 3,817,814 (20%) | 1% | 5.4 | 1,717,108 | Common Stock |
| Applied Therapeutics Inc | Shendelman Shoshana | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 1,100,000 | 3,696,387 (19%) | 5% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 440,000 | 4,136,387 (22%) | 2% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 30 Nov 2023 | 3,968 | 2,596,387 (14%) | 0% | 2.0 | 7,817 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 27 Sep 2023 | 115,632 | 2,600,355 (14%) | 0% | 2.7 | 312,206 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 1,964,362 | 2,715,987 (14%) | 10% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 11 Jan 2023 | 15,870 | 751,625 (4%) | 0% | 0.9 | 14,442 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 14 Oct 2022 | 50,000 | 767,495 (4%) | 0% | 0.6 | 32,250 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 Oct 2022 | 73,256 | 717,495 (3%) | 0% | 0.6 | 40,891 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 12 Oct 2022 | 38,153 | 644,239 (3%) | 0% | 0.5 | 19,943 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 607,484 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 607,484 | 607,484 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 234,616 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 234,616 | 234,616 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,979 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,979 | 134,979 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 101,670 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 101,670 | 101,670 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 23,317 | 23,317 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 23,317 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 234,616 | 234,616 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 120,900 | 606,086 (3%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 80,600 | 80,600 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 120,900 | 485,186 (2%) | 0% | 0 | Common Stock | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 80,600 | 80,600 | - | - | Employee Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.49 per share. | 13 Sep 2021 | 9,300 | 364,286 (1%) | 0% | 14.5 | 134,740 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.69 per share. | 13 Sep 2021 | 701 | 354,986 (1%) | 0% | 14.7 | 10,298 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 256,850 | 256,850 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 539,609 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 554,609 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 569,609 | - | - | Stock Option (Right to Buy) | |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.19 per share. | 20 Jul 2020 | 12,100 | 557,185 (3%) | 0% | 27.2 | 328,999 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.45 per share. | 20 Jul 2020 | 12,051 | 557,235 (3%) | 0% | 25.5 | 306,698 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 20 Jul 2020 | 7,600 | 561,685 (3%) | 0% | 26.7 | 202,844 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.42 per share. | 20 Jul 2020 | 7,300 | 554,385 (2%) | 0% | 27.4 | 200,166 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.51 per share. | 20 Jul 2020 | 2,949 | 554,285 (2%) | 0% | 26.5 | 78,178 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.88 per share. | 20 Jul 2020 | 2,600 | 554,585 (2%) | 0% | 27.9 | 72,488 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 20 Jul 2020 | 300 | 554,285 (2%) | 0% | 28.6 | 8,592 | Common Stock |
| Applied Therapeutics Inc | Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.24 per share. | 20 Jul 2020 | 100 | 554,285 (2%) | 0% | 28.2 | 2,824 | Common Stock |